ReviewThe Journal of experimental medicine2000
Turning on natural killer cells.
Review in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- FcγR-driven chimeric receptor T cells in cancer therapy: a novel frontier in antibody-guided immunotherapy.Cancer cell international · 2026Review
- Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.Life science alliance · 2022Article
- Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.Genome medicine · 2021Article
- Elucidation of the molecular interactions that enable stable assembly and structural diversity in multicomponent immune receptors.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.Cancers · 2021Article
- BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis.Journal for immunotherapy of cancer · 2020Article
- Natural Killer Cells and Host Defense Against Human Rhinoviruses Is Partially Dependent on Type I IFN Signaling.Frontiers in cellular and infection microbiology · 2020Article
- Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.Frontiers in immunology · 2017Article
- Natural Killer Cells in the Orchestration of Chronic Inflammatory Diseases.Journal of immunology research · 2017Review
- NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma.Frontiers in medicine · 2015Review
- The immunomodulating roles of glycoproteins in epithelial ovarian cancer.Frontiers in bioscience (Elite edition) · 2012Review
- Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.Oncogene · 2011Article
- Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials.Transplantation · 2009Review
- Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.Journal of immunology (Baltimore, Md. : 1950) · 2008Article
- Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.Transplantation · 2008Article
- Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation.Cancer immunology, immunotherapy : CII · 2006Article
- NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.Clinical and experimental immunology · 2006Article
- Article
- NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.Cancer immunology, immunotherapy : CII · 2005Article
- Enforced expression of EBF in hematopoietic stem cells restricts lymphopoiesis to the B cell lineage.The EMBO journal · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.